U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage

August 1, 2026 10:00 AM

Management commentary is likely to be more important than Q2 numbers for most U.S. biopharma stocks as they report quarterly ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found